bioRxivCancer BiologyPreprint
Cooperative Modular Representation Learning for Lung Adenocarcinoma Survival Prediction from Transcriptomic and Clinical Data
SUNDUS MUHAMMAD JASIMiD, Nabil HeziliD, Ahmed BouridaneiD, Rifat HamoudiiD
Abstract
Accurate prognosis in lung adenocarcinoma (LUAD) requires integration of high-dimensional transcriptomic profiles with compact but clinically stable patient covariates. Naive fusion strategies allow the high-variance RNA-seq modality to dominate learned representations, suppressing clinical signal. We present Cooperative Modular Representation Learning (CMRL), an uncertainty-gated multimodal framework that dynamically regulates inter-modality information flow based on sample-level epistemic uncertainty estimated via Evidential Deep Learning (EDL). Each modality encoder produces a latent embedding and a scalar uncertainty score; an adaptive communication gate controls how much each module updates its representation from messages sent by the other module. A Variational Information Bottleneck (VIB) on the transcriptomic encoder further suppresses noise in the high-dimensional genomic latent space. CMRL is evaluated via 5-fold stratified cross validation on 490 TCGA-LUAD patients with matched RNA-seq (504 features) and clinical data. It achieves a concordance index (C-index) of 0.732 {+/-} 0.024, AUROC of 0.772 {+/-} 0.019, and AUPRC of 0.773 {+/-} 0.056 for 3-year survival prediction, outperforming a concatenation-fusion baseline (C-index 0.656), RNA-only (0.711), and clinical-only (0.670) variants, as well as several published LUAD survival models including CustOmics (0.625) and a whole-slide imaging method (0.675). An ablation study confirms that the uncertainty gate and evidential heads each contribute independently to the gain. Calibration analysis yields an Expected Calibration Error of 0.122, and uncertainty-stratified evaluation shows that low-uncertainty patients achieve AUROC 0.795 versus 0.681 for high-uncertainty patients, providing interpretable evidence that the gate mechanism is functioning as intended.
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: deep learning
- approach: variational autoencoder
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clinical-Anchored Incremental Survival Learning: A Stability-Constrained Framework for Molecularly Enhanced Survival Prediction in Lung Adenocarcinoma
Parth Shringarpure, Sonica Divakar, Shrutika Khobragade·bioRxiv·Nov 5, 2026
- SPARK: A Systems-level Computational Framework for Reconstructing Transcriptomic State Organisation in Lung Adenocarcinoma
Rishabh Kulkarni, Avik Sengupta, Rahul Kumar·bioRxiv·Jun 11, 2026
- A Multimodal Neural Network Model for Early Recurrence Prediction in Lung Adenocarcinoma
Jessica Patricoski, Karma Hayek, … Ece Dilber Gamsiz Uzun·bioRxiv·May 18, 2026
- DeepMPS: Development and validation of a deep learning model for whole slide image base prognostic prediction of low grade Lung adenocarcinoma patients
A. Jagjampi, S. Khadirnaikar, … S. Shukla·bioRxiv·Dec 27, 2022
- A prognostic signature for lung adenocarcinoma in people who have never smoked
Wei Zhao, Tongwu Zhang, … Maria Teresa Landi·bioRxiv·Aug 13, 2025
- A risk stratification model for lung cancer based on gene coexpression network
Hongyoon Choi, Kwon Joong Na·BioMed Research InternationalPeer-reviewed·Jan 1, 2018